Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-11
DOI
10.1007/s40262-023-01305-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses
- (2023) Lucas Perez et al. Journal of Fungi
- Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis
- (2022) Rainer Höhl et al. MYCOSES
- Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
- (2021) Antonio C. Arrieta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
- (2021) Juergen Prattes et al. CLINICAL MICROBIOLOGY AND INFECTION
- COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
- (2020) Amir Arastehfar et al. Journal of Fungi
- Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
- (2019) E Furfaro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
- (2018) Alexander F A D Schauwvlieghe et al. Lancet Respiratory Medicine
- Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
- (2018) Bart Jan Kullberg et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi
- (2016) Amit Desai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling
- (2016) Anne-Gaëlle Dosne et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
- (2010) Marta Ulldemolins et al. CLINICAL PHARMACOKINETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search